Valtrex and Multiple sclerosis relapse - a phase IV clinical study of FDA data
Multiple sclerosis relapse is found among people who take Valtrex, especially for people who are female, 40-49 old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Valtrex and have Multiple sclerosis relapse. It is created by eHealthMe based on reports of 32,398 people who have side effects when taking Valtrex from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
32,398 people reported to have side effects when taking Valtrex.
Among them, 138 people (0.43%) have Multiple sclerosis relapse.
What is Valtrex?
Valtrex has active ingredients of valacyclovir hydrochloride. It is often used in genital herpes. eHealthMe is studying from 34,253 Valtrex users for its effectiveness, alternative drugs and more.
What is Multiple sclerosis relapse?
Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath) is found to be associated with 1,466 drugs and 850 conditions by eHealthMe.
Number of Valtrex and Multiple sclerosis relapse reports submitted per year:
Time on Valtrex when people have Multiple sclerosis relapse *:
Gender of people who have Multiple sclerosis relapse when taking Valtrex*:
Age of people who have Multiple sclerosis relapse when taking Valtrex *:
Common drugs people take besides Valtrex *:
Common side effects people have besides Multiple sclerosis relapse *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Valtrex and have Multiple sclerosis relapse?Check whether Multiple sclerosis relapse is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Alternative drugs to, pros and cons of Valtrex:
- Valtrex (34,253 reports)
Multiple sclerosis relapse treatments and more:
- Multiple sclerosis relapse (72,843 reports)
COVID vaccines that are related to Multiple sclerosis relapse:
- Multiple sclerosis relapse in Moderna COVID Vaccine
- Multiple sclerosis relapse in Pfizer BioNTech Covid Vaccine
- Multiple sclerosis relapse in Johnson and Johnson Covid Vaccine
How severe was Multiple sclerosis relapse and when was it recovered:
Expand to all the drugs that have ingredients of valacyclovir hydrochloride:
Common drugs associated with Multiple sclerosis relapse:
All the drugs that are associated with Multiple sclerosis relapse:
- Multiple sclerosis relapse (1,466 drugs)
Common conditions associated with Multiple sclerosis relapse:
All the conditions that are associated with Multiple sclerosis relapse:
- Multiple sclerosis relapse (850 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on valacyclovir hydrochloride (the active ingredients of Valtrex) and Valtrex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.